Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
about
The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cellsLentiviral vector gene therapy: effective and safe?In Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A VirusesA self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in miceIncomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells.In-vivo RGB marking and multicolour single-cell tracking in the adult brainGene therapy of MPL deficiency: challenging balance between leukemia and pancytopenia.Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance.Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.Protein transduction from retroviral Gag precursorsNeonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in mice.Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.Translating Sleeping Beauty transposition into cellular therapies: victories and challenges.Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfectionGammaretroviral vectors: biology, technology and applicationEfficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments.High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages.Avoiding cytotoxicity of transposases by dose-controlled mRNA deliveryAlpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.Reducing the genotoxic potential of retroviral vectors.Sites of retroviral DNA integration: From basic research to clinical applicationsCombinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesThe long and winding road that leads to a cure for epidermolysis bullosa.Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.Multimodal Lentiviral Vectors for Pharmacologically Controlled Switching Between Constitutive Single Gene Expression and Tetracycline-Regulated Multiple Gene Collaboration.Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.Retroviral Transduction of T Cells and T Cell PrecursorsTetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization.Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.Improved retroviral episome transfer of transcription factors enables sustained cell fate modification.Evolving Gene Therapy in Primary Immunodeficiency.Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas.Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.Self-inactivating alpharetroviral vectors with a split-packaging design.Long-term in vivo single-cell tracking reveals the switch of migration patterns in adult-born juxtaglomerular cells of the mouse olfactory bulbA new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration.
P2860
Q21090492-6534414A-27A4-4D96-9A5D-56CED0802512Q24630888-72E07749-DE7D-41B5-A1E6-F2EE72715658Q30375878-943F00AD-F620-42EA-979D-C30D4ACD7ED7Q30493690-C3D77C78-7E4E-4EAF-8779-138C35F71326Q30560427-D5E8EDEE-8937-4020-99D3-A146ED2BDE4AQ30610594-5BF88CD3-822A-4E52-893A-3FC3D090FC40Q33386724-A23824FC-EE77-4519-9105-E11A9DA010D4Q33424158-0241E2FF-C016-49A4-B86E-4BEEC0E9ED91Q33712953-6CCEE3C7-19CB-4077-8024-6FDD011E288EQ33713156-C0A4F89C-1058-473E-883B-9E9BEAE3CFFDQ33713961-DF4AA569-ADF5-4EF7-A87A-B1776468FC9DQ33842785-0339CB66-0427-463E-8CC7-FCCF3CE9BFD3Q33936562-DD23FAA0-2779-4876-BFB2-95DDB4211987Q33937526-85720812-1252-43B3-964B-B9D923CCAF41Q34127579-B0F9F640-B1E2-48FD-8C88-21C29731BFD6Q34204409-68B18195-BE4E-4A14-9C7A-296D56AF20E4Q34223822-38278D7C-585F-4486-AEF4-BCE25289F44CQ34459383-A7D51485-D23E-47E7-9D94-ECFD97F4C9D2Q34641722-ACDC8B70-01DE-4D45-91D2-78E812A20713Q35198350-4AAF7C88-08FB-46AC-A10D-8C234FC593DAQ35939492-98B466C7-2A28-4E8C-A901-0A395FCE4D2EQ36248825-0E3843D0-AFE0-4918-96CA-F3385A3C0407Q36670724-49C35A8D-9EBD-4DF1-9E44-478A5192FE9CQ36900663-128A5CB7-EC1F-40FD-828B-ADA2F116E040Q37021156-AFB66DCA-1485-4102-94C2-20305143BB02Q37358371-F9B141AE-FC3E-4398-B3B7-E4DA06B8ADB2Q38119245-66114295-5A7F-402E-BF60-19A3B329C64BQ38285765-57DDEA5A-00D7-4F28-B7D7-690764E70CB8Q38697932-6E38E07D-9626-475E-8162-E3076B9E9BFBQ38751544-9AE21FEE-1F86-4A84-8663-7F2A66D88C1EQ38842119-CCFD5AD8-E999-4474-806B-15F9627D117BQ38944125-728A34FC-D383-4A8A-82C2-782F28A012A9Q38952592-BEECA39E-728D-4E17-9FEC-92821451A0B5Q38968105-1AA104C7-AF6C-44D5-A1E3-5A8C5B48852BQ39214064-73AAD4FE-7F24-4914-BB15-989382F7E4F5Q39305389-C2E1793B-70EE-42F2-99DB-03174522F36AQ39644492-FA4FDAA0-63AD-4337-8BBF-9570BE278411Q39712155-8C955031-28C0-4D9C-8AB6-43CB4545274BQ39770523-1E603A77-5829-454A-8518-51928EB2DFE7Q39782235-E0041D6F-1ABE-483B-8E15-924E37113D78
P2860
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Overcoming promoter competitio ...... activating retroviral vectors.
@en
type
label
Overcoming promoter competitio ...... activating retroviral vectors.
@en
prefLabel
Overcoming promoter competitio ...... activating retroviral vectors.
@en
P2093
P2860
P356
P1433
P1476
Overcoming promoter competitio ...... activating retroviral vectors.
@en
P2093
Schambach A
Verstegen MM
Wagemaker G
P2860
P2888
P304
P356
10.1038/SJ.GT.3302807
P577
2006-06-08T00:00:00Z
P5875
P6179
1022955922